SB 253 requires Oklahoma's Medicaid agency (the Oklahoma Health Care Authority) to include specific funding details in its annual budget request. It mandates that the budget reflect new state and federal funding needed to cover the most recent audited costs for reimbursing nursing facilities and intermediate care facilities serving individuals with intellectual disabilities. The audited cost must be calculated using the latest cost report submitted to the agency. This change takes effect November 1, 2025.
SB 1383 requires Oklahoma Medicaid to cover diabetes self-management education and support (DSMES) for beneficiaries with diabetes. It mandates the Oklahoma Health Care Authority to develop a state plan amendment for this coverage after completing a feasibility study and reporting on costs, clinical evidence, and pilot results. The bill defines DSMES as personalized education covering healthy eating, physical activity, blood sugar monitoring, and medication management. This policy change directly affects Oklahoma Medicaid enrollees diagnosed with diabetes by expanding their covered health services. The bill becomes effective November 1, 2026.
HB 2923 creates the Oklahoma Prisoner Reentry Pilot Program to support inmates transitioning from prison to community life. It directly affects inmates under the Department of Corrections' jurisdiction who have a medium or high risk of felony re-arrest, focusing on those in counties with over 500,000 residents. The bill requires the Department to provide case management services connecting participants to 14 specific support areas, including housing, job training, healthcare, substance abuse treatment, and transitional services like transportation. The program must be evaluated annually to assess recidivism reduction, with results reported to the Legislature and Governor, and becomes effective November 1, 2025.
SB 496 amends Oklahoma's Governmental Tort Claims Act by clarifying key definitions in Section 152. It specifically defines "charitable health care provider" as entities offering free care to medically indigent patients and expands "community health care provider" to include those working with federally qualified health centers or pending applications. The bill also broadens "employee" to explicitly include certain healthcare professionals (like administrative physicians, resident doctors, and mental health staff) under state contracts. These changes directly affect healthcare providers, state agencies, and individuals filing tort claims against the state or political subdivisions. The amendment aims to clarify eligibility under the tort claims process without altering core legal procedures.
SB 1064 requires health insurance plans in Oklahoma to use evidence-based clinical guidelines when creating step therapy protocols (where insurers mandate trying cheaper drugs first). It mandates that insurers provide a clear, accessible process for doctors and patients to request exceptions when step therapy blocks necessary medications, and they must grant exceptions if the doctor provides justification (e.g., prior drug failure, adverse reactions, or medical necessity). Insurers must respond to exception requests within 72 hours (24 hours for emergencies), and failure to respond on time automatically grants the exception. The bill directly affects insurers, healthcare providers, and patients using prescription drugs covered under step therapy protocols.
HB 2049 requires Oklahoma's Medicaid managed care plans to comply with federal parity laws for mental health and substance use disorder coverage. It mandates regular compliance checks on nonquantitative treatment limitations (like prior authorization), creates a standardized process for handling parity complaints, and requires the Oklahoma Health Care Authority to publicly report on compliance. The law directly affects Medicaid managed care plans, the Oklahoma Health Care Authority, and Medicaid beneficiaries seeking mental health or substance use services. Key provisions include contract requirements for parity analysis, public disclosure of compliance reports, and a 30-day deadline for publishing federal reports. The bill became effective November 1, 2025.
This bill prevents health insurers from changing coverage for a prescription drug after it has been preapproved and the patient has already started taking it. It specifically prohibits insurers from increasing costs, denying coverage, moving the drug to a higher-cost tier, or switching to a generic without consent. Exceptions only apply if the FDA issues a safety warning or the drug manufacturer discontinues production. This directly protects patients with ongoing prescriptions who rely on specific medications.
SB 889 requires Oklahoma hospitals to publicly post detailed pricing information online in an accessible, machine-readable format. It directly affects licensed hospitals and state-owned hospital facilities by mandating they publish a digital list of standard charges for all services, including gross charges, discounted cash prices, and negotiated rates with insurers. The bill specifies that hospitals must display this information free of charge, without requiring user accounts, and update it annually on their public website. This transparency measure aims to help patients compare costs for services like procedures, room fees, and supplies before receiving care.
HB 1988 expands Oklahoma's Medicaid program to cover adults aged 19 to 64 with household incomes at or below 160% of the federal poverty level. This change directly affects low-income working adults and families who previously did not qualify for Medicaid under Oklahoma's current eligibility rules. The Oklahoma Health Care Authority must implement this expanded coverage starting November 1, 2025. The bill modifies eligibility criteria to include this income group without altering existing Medicaid benefits or funding mechanisms.
SB 741 allows Oklahoma pharmacists to test for and start treatment for minor, nonchronic health conditions (like colds or minor skin infections) under a standing order from a physician or health department director. Pharmacists must use only FDA-approved, CLIA-waived tests for screening and cannot test for strep throat or prescribe antibiotics to children under six. This directly expands pharmacists' clinical role for common, non-serious conditions while requiring specific safeguards. The bill amends Oklahoma's pharmacy law to clarify these new responsibilities and prohibitions.
